SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-004891 to Molecular Templates, Inc. (MTEM) (CIK 0001183765)

Molecular Templates, Inc. (MTEM) (CIK 0001183765)
Date: May 1, 2024 · CIK: 0001183765 · Accession: 0000000000-24-004891

AI Filing Summary & Sentiment

File numbers found in text: 333-278932

Date
May 1, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Molecular Templates, Inc. (MTEM) (CIK 0001183765)

Letter

United States securities and exchange commission logo May 1, 2024 Eric E. Poma, Ph.D. Chief Executive Officer and Chief Scientific Officer Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin, Texas 78729 Re:Molecular Templates, Inc. Registration Statement on Form S-3 Filed April 25, 2024 File No. 333-278932 Dear Eric E. Poma: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Melanie Ruthrauff Levy, Esq.

Show Raw Text
United States securities and exchange commission logo
May 1, 2024
Eric E. Poma, Ph.D.
Chief Executive Officer and Chief Scientific Officer
Molecular Templates, Inc.
9301 Amberglen Blvd, Suite 100
Austin, Texas 78729
Re:Molecular Templates, Inc.
Registration Statement on Form S-3
Filed April 25, 2024
File No. 333-278932
Dear Eric E. Poma:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Melanie Ruthrauff Levy, Esq.